Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

tuberculosis

TB043 Tuberculosis Study – A BCG challenge study in healthy adults to help develop TB vaccines.  If you are aged 18-50, in good health, and have never received the BCG vaccine, you may be eligible to participate.  The study involves 9-11 visits over a period of around 6 months. Participants will be reimbursed for their time and travel from £705 to £750. Click here for more information.

RIFT VALLEY FEVER

RVF001 - A phase I study to determine the safety and immunogenicity of the Rift Valley Fever (RVF) vaccine in healthy adult participants.  If you are aged 18-50 and are in good health, you may be eligible to participate.  The trial will involve 8 visits over a period of 3 months and participants will receive around £370 on completion of the study. Click here for more information.

Zika Vaccine 

ZIKA001 - A phase I study to determine the safety and immunogenicity of the candidate Zika Virus (ZIKV) vaccine ChAdOx1 Zika in healthy adult volunteers. If you are aged 18-50 and are in good health, you may be eligible to participate. The trial will involve 9 visits over a period of 6 months and participants will receive up to £415 on completion of the study. Click here for more information.

COVID-19 Vaccine development

For information about COV001 and COV002 COVID-19 Oxford Vaccine studies, please visit: https://covid19vaccinetrial.web.ox.ac.uk. Recruitment for these studies is now complete. 

 

Would you like to keep up to date with trials?

If you would like to register with us to receive our monthly email newsletter detailing our latest trials looking for volunteers, please click here.